Clinical Trial Update: Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating ACLF [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial investigates umbilical cord-derived mesenchymal stem cell infusions for acute-on-chronic liver failure, spanning Phase 2 and Phase 3, and is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• Umbilical Cord-derived Mesenchymal Stem Cell Infusion (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: National Engineering Center of Cell Products | Conditions: Acute-On-Chronic Liver Failure | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING